PHASE III MEDICAL, INC.

Company

LISATA THERAPEUTICS, INC.

Filed

June 22, 2005

Period of Report

July 20, 2005

Accession Number

0000950144-05-006687

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →